Skip to content Skip to footer

2008

Conference Publication

Absorption and pharmacokinetics of bilirubin and biliverdin administration in the rat

Bulmer, A.C., Coombes, J.S., Blanchfield, J.T., Toth, I. and Taylor, S.M. (2008). Absorption and pharmacokinetics of bilirubin and biliverdin administration in the rat. Australian Health and Medical Research Congress, Brisbane, 16 - 21 November, 2008.

Absorption and pharmacokinetics of bilirubin and biliverdin administration in the rat

2008

Conference Publication

Synthesis and in vivo studies of carbohydrate-based vaccines against group A Streptococcus

Simerska, Pavla, Abdel-Aal, Abu-Baker M., Fujita, Yoshio, Batzloff, Michael R., Good, Michael F. and Toth, Istvan (2008). Synthesis and in vivo studies of carbohydrate-based vaccines against group A Streptococcus. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/bip.20992

Synthesis and in vivo studies of carbohydrate-based vaccines against group A Streptococcus

2007

Conference Publication

The Characterisation of Novel Dendritic Carriers with DNA by Isothermal Titration Calorimetry

Coles, D., Yang, S., Esposito, A., Mitchell, D., Minchin, R. and Toth, I. (2007). The Characterisation of Novel Dendritic Carriers with DNA by Isothermal Titration Calorimetry. 4th International Peptide Symposium, Cairns, 21-25 October 2007. Australia: Australian Peptide Association.

The Characterisation of Novel Dendritic Carriers with DNA by Isothermal Titration Calorimetry

2007

Conference Publication

Vaccine delivery: Synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate

Toth, I., Moyle, P. M., Simerska, P., Fujita, Y., Olive, C. and Good, M. F. (2007). Vaccine delivery: Synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate. 20th American Peptide Symposium, Montréal, Quebec, Canada, 26-30 June 2007. HOBOKEN: Wiley Periodicals. doi: 10.1002/bip.20783

Vaccine delivery: Synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate

2007

Conference Publication

Peptide-lipid-carbohydrate based vaccine against group A Streptococcal infection.

Simerska, P., Abdel-Aal, A. B., McGeary, R., Moyle, P.M., Fujita, Y., Good, M.F. and Toth, I. (2007). Peptide-lipid-carbohydrate based vaccine against group A Streptococcal infection.. 13th International Congress of Immunology, Rio de Janeiro, Brazil, August 21-25.

Peptide-lipid-carbohydrate based vaccine against group A Streptococcal infection.

2007

Conference Publication

Liposaccharides in Peptide Vaccine Delivery

Simerska, P., Moyle, P. M., Abdel-Aal, A. M., Fujita, Y., Olive, C., Batzloff, M. R., Good, M. F. and Toth, I. (2007). Liposaccharides in Peptide Vaccine Delivery. 4th International Peptide Symposium, Cairns, 21-25 October 2007. Australia: Australian Peptide Association.

Liposaccharides in Peptide Vaccine Delivery

2007

Conference Publication

The importance of epitope and lipid orientation in the design of synthetic self-adjuvanting group A streptococcal (GAS) vaccine

Abdel-Aal, A. M., Batzloff, M. R., Faria, A., Fujita, Y., Good, M. F., Phillipps, K. S. M., Simerska, P., Toth, I. and Zaman, M. (2007). The importance of epitope and lipid orientation in the design of synthetic self-adjuvanting group A streptococcal (GAS) vaccine. 4th international Peptide Symposium in conjunction with the 7th Australian Peptide Conference and the 2nd Asia-Pacific International Peptide Symposium, 2007, Cairns, Queensland, Australia, 21 - 25 October 2007. Australian Peptide Association.

The importance of epitope and lipid orientation in the design of synthetic self-adjuvanting group A streptococcal (GAS) vaccine

2007

Conference Publication

Enhancement of Oral Drug Absorption - Effect of Lipid and Glycoside Conjugation on the Enzymatic Stability and Intestinal Permeability of IM862

Bergeon, J., Chan, Y. and Toth, I. (2007). Enhancement of Oral Drug Absorption - Effect of Lipid and Glycoside Conjugation on the Enzymatic Stability and Intestinal Permeability of IM862. 4th International Peptide Symposium, Cairns QLD Australia, 21-25 October 2007. Australia: Australian Peptide Association.

Enhancement of Oral Drug Absorption - Effect of Lipid and Glycoside Conjugation on the Enzymatic Stability and Intestinal Permeability of IM862

2007

Conference Publication

Vaccine Delivery Utilizing Liposaccharides

Simerska, P., Moyle, P. M., Zhong, W., McGeary, R., Abdel-Aal, A. B., Good, M. F. and Toth, I. (2007). Vaccine Delivery Utilizing Liposaccharides. 20th American Peptide Symposium, Montréal, Quebec, Canada, 26-30 June 2007. Hoboken: John Wiley & Sons. doi: 10.1002/bip.20783

Vaccine Delivery Utilizing Liposaccharides

2007

Conference Publication

Development of a Multivalent Heteroepitopic Group A Streptococcus Vaccine

Fujita, Y., Moyle, P., Abdel-Aal, A., Batzloff, M., Good, M. and Toth, I. (2007). Development of a Multivalent Heteroepitopic Group A Streptococcus Vaccine. 4th International Peptide Symposium, Cairns, 21-25 October 2007. Australia: Australian Peptide Association.

Development of a Multivalent Heteroepitopic Group A Streptococcus Vaccine

2007

Conference Publication

Novel lipoamino acid based vaccine adjuvant carrier system

Toth, I., Moyle, P. M., Simerska, P., Fujita, Y., Olive, C. and Good, M. F. (2007). Novel lipoamino acid based vaccine adjuvant carrier system. International Congress of Immunology, Rio de Janeiro, Brazil, 21-25 August 2007. Toronto, Canada: Hogrefe & Huber.

Novel lipoamino acid based vaccine adjuvant carrier system

2006

Conference Publication

Epidermal penetration of a therapeutic peptide by lipid conjugation; stereo-selective peptide availability of a topical diastereomeric lipopeptide

Caccetta, Rima, Blanchfield, Joanne T., Harrison, Jessica, Toth, Istvan and Benson, Heather A. E. (2006). Epidermal penetration of a therapeutic peptide by lipid conjugation; stereo-selective peptide availability of a topical diastereomeric lipopeptide. doi: 10.1007/s10989-006-9024-5

Epidermal penetration of a therapeutic peptide by lipid conjugation; stereo-selective peptide availability of a topical diastereomeric lipopeptide

2006

Conference Publication

Development of totally synthetic self-adjuvanting vaccines against Group A streptococcus

Abdel-Aal, A. M., Fujita, Y., Faria, A., Simerska, P., Batzloff, M. R., Good, M. F. and Toth, I. (2006). Development of totally synthetic self-adjuvanting vaccines against Group A streptococcus. Annual Conference of the Australasian Pharmaceutical Science n, Adelaide, Australia, 3-5 December 2006. Malvern, VIC: Australasian Pharmaceutical Science Association.

Development of totally synthetic self-adjuvanting vaccines against Group A streptococcus

2006

Conference Publication

The synthesis of a novel dendritic system for gene delivery

Coles, D. J., Yang, S, Esposito, A., Mitchell, D J, Minchin, R F and Toth, I (2006). The synthesis of a novel dendritic system for gene delivery. Brisbane Biological & Organic Chemistry Symposium, Brisbane, 24 November 2006.

The synthesis of a novel dendritic system for gene delivery

2006

Conference Publication

Liposaccharides in peptide, gene and vaccine delivery

Toth, I, Moyle, P. M., Koda, Y., Olive, C. and Good, M F (2006). Liposaccharides in peptide, gene and vaccine delivery. 10th Naples Workshop on Bioactive Peptides, Naples, 11-14 June, 2006.

Liposaccharides in peptide, gene and vaccine delivery

2006

Conference Publication

The chemo-enzymatic synthesis of oligosaccharide-linked peptides aimed at improved drug delivery

Johnstone, Ken D., Dieckelmann, Manuela, Jennings, Michael P., Blanchfield, Joanne T. and Toth, Istvan (2006). The chemo-enzymatic synthesis of oligosaccharide-linked peptides aimed at improved drug delivery. 19th American Peptide Symposium, San Diego, CA, United States, 18-23 June 2005. New York, NY, United States: Springer. doi: 10.1007/978-0-387-26575-9_221

The chemo-enzymatic synthesis of oligosaccharide-linked peptides aimed at improved drug delivery

2006

Conference Publication

Caco-2 cell permeability and stability assays of two d-glycopyranuronanamide conjugates of thyrotropic releasing hormone

Wessling, S., Ross, B P, Blanchfield, J T and Toth, I (2006). Caco-2 cell permeability and stability assays of two d-glycopyranuronanamide conjugates of thyrotropic releasing hormone. Brisbane Biological & Organic Chemistry Symposium, Brisbane, 24 Nov 2006.

Caco-2 cell permeability and stability assays of two d-glycopyranuronanamide conjugates of thyrotropic releasing hormone

2006

Conference Publication

Synthetic lipopeptides formulated in liposomes: Effect on their immune stimulatory capacity in vitro

Liang, M, Hennessy, T., Toth, I, Davies, N M and Hook, S. (2006). Synthetic lipopeptides formulated in liposomes: Effect on their immune stimulatory capacity in vitro. 2006 International Conference on Nanoscience and Nanotechnoloy, Brisbane / Brisbane Convention Centre, 3-7 July 2006. Canberra: IEEE.

Synthetic lipopeptides formulated in liposomes: Effect on their immune stimulatory capacity in vitro

2006

Conference Publication

Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer

Simerska, P., Moyle, P. M., Olive, C., Sun, H. K., Ho, M. F., Pandy, M. G., Dyer, J. R., Burgess, M. L. and Toth, I. (2006). Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer. GPEN 2006, Lawrence, USA, 25-27 October, 2006.

Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer

2006

Conference Publication

Development of peptide vaccines against HPV-16 associated cervical cancer and group a streptococci

Moyle, Peter M., Horvath, Aniko, Karpati, Levente, Olive, Colleen, Barozzi, Nadia, Wimmer, Norbert, Good, Michael and Toth, Istvan (2006). Development of peptide vaccines against HPV-16 associated cervical cancer and group a streptococci. 19th American Peptide Symposium, San Diego, United States, 18-23 June 2005. New York, United States: Springer. doi: 10.1007/978-0-387-26575-9_169

Development of peptide vaccines against HPV-16 associated cervical cancer and group a streptococci